跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROCURONIUM BROMIDE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ROCURONIUM BROMIDE INJECTION
Authorized
STANDARD
ROCURONIUM BROMIDE INJECTION
Juno Pharmaceuticals Corp.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b7244e5df03ea50d
Company
Juno Pharmaceuticals Corp.
Type
Standard
Approval Details
Approval Id
b7244e5df03ea50d
Drug Approval Canada Name
ROCURONIUM BROMIDE INJECTION
Product Name
ROCURONIUM BROMIDE INJECTION
Status
Marketed
Status Date
2021-11-15
Original Market Date
2019-01-17
Din
02469774
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
12:20.20
Atc Original
M03AC09 ROCURONIUM BROMIDE
Atc Name
m 03 ac 09
Aig Number
0126317001
Company Name
Juno Pharmaceuticals Corp.
Company Address
402, 2233 Argentia Road, Mississauga, Ontario, Canada, L5N 2X7
Active Ingredients
ROCURONIUM BROMIDE
10 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b7244e5df03ea50d
Type
Standard
Back to Health Canada Approvals